FDA approves first in class targeted therapy for metastatic pancreatic cancer

Posted by leopoldj on 2026-08-26 · fda.gov

Discussion record

The retained reading has not passed independent publication checks. Its summary is withheld.

The summary gate never changes the score, comment count, story metadata, or retained-history figures above.